BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 31766537)

  • 21. The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?
    Fernández L; Duarte AC; Rodríguez A; García P
    Benef Microbes; 2021 Apr; 12(2):107-120. PubMed ID: 33789552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phages amid antimicrobial resistance.
    Mohan Raj JR; Karunasagar I
    Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-evolutionary dynamics of the bacteria Vibrio sp. CV1 and phages V1G, V1P1, and V1P2: implications for phage therapy.
    Barbosa C; Venail P; Holguin AV; Vives MJ
    Microb Ecol; 2013 Nov; 66(4):897-905. PubMed ID: 24013213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological foundations of successful bacteriophage therapy.
    Venturini C; Petrovic Fabijan A; Fajardo Lubian A; Barbirz S; Iredell J
    EMBO Mol Med; 2022 Jul; 14(7):e12435. PubMed ID: 35620963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phage Therapy Faces Evolutionary Challenges.
    Torres-Barceló C
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29895791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More than Simple Parasites: the Sociobiology of Bacteriophages and Their Bacterial Hosts.
    Secor PR; Dandekar AA
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
    Mangalea MR; Duerkop BA
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Creation of synthetic bacterial viruses].
    Ando H
    Nihon Saikingaku Zasshi; 2018; 73(4):201-210. PubMed ID: 30487377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The disparate effects of bacteriophages on antibiotic-resistant bacteria.
    Torres-Barceló C
    Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phage Therapy: The Pharmacology of Antibacterial Viruses.
    Danis-Wlodarczyk K; Dąbrowska K; Abedon ST
    Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phages Needed against Resistant Bacteria.
    Moelling K
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32664292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacteriophages in the battle against multidrug resistant bacteria].
    van der Meer JWM; Vandenbroucke-Grauls CMJE
    Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of phage-mediated biocontrol of bacteria.
    Abedon ST
    Foodborne Pathog Dis; 2009 Sep; 6(7):807-15. PubMed ID: 19459758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
    Segall AM; Roach DR; Strathdee SA
    Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.